The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...

Kennedy Jr., has severely restricted the use of the NovavaxCOVID-19 vaccine. The vaccine will now only be available to ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval. HealthDay News — Novavax’s COVID-19 vaccine could soon receive full ...

Novavax’s COVID-19 vaccine could soon receive full approval from the US Food and Drug Administration (FDA). HealthDay News — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S.

The FDA was on track to grant Novavax full approval by its April 1 target date, according to two people with direct knowledge of the situation who spoke on condition of anonymity to discuss ...